Skip to main content

Eczema Content

News
Findings from a recent study showed patients with moderate to severe atopic dermatitis had a high burden of ocular surface disorders and related symptoms.
NEA Approved Features, Partners
Lauren Mateja, Managing Editor
As research continues to better differentiate between eczema and other diagnoses, the National Eczema Association continues to push awareness among patients and physicians with Eczema Awareness Month.
News
A synthetic indolicidin analogue antimicrobial peptide with activity against Staphylococcus aureus improved dysbiosis but not the clinical signs of atopic dermatitis.
News
A recent randomized clinical trial showed baricitinib combined with topical corticosteroids improved the signs and symptoms of moderate to severe atopic dermatitis.
News
Findings from a recent study showed crisaborole ointment quickly and effectively improved mild to moderate atopic dermatitis among pediatric patients.
News
Findings from a recent study showed dupilumab was safe and effective for treating treatment-resistant atopic dermatitis over a year in a real-world setting.
News
A recent review investigated the mechanisms, diagnosis, and management of infectious complications associated with atopic dermatitis, including the use of antibiotics.
News
Findings from a recent study suggest that topical calcineurin inhibitors are not associated with an increased risk of keratinocyte carcinomas among adult patients with atopic dermatitis.
Features
Brad Shumel, MD, Ana B. Rossi, MD, CMD
This visual 12-patient series by Drs Shumel and Rossi demonstrates the efficacy of dupilumab in patients aged 6 to 11 years with severe atopic dermatitis treated over a 16-week period.
News
Findings from two large cohort studies highlighted the potential association between atopic dermatitis (AD), overall and specific cancer risks, and the influence of AD severity on this risk.
Back to Top